January 9, 2024 by Scott Melville
CHPA, Health care outlook 2024: Scott Melville, president and CEO
January 22, 2024, Opinion, Pharmacy
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The year 2023 marked another significant milestone for consumer health care with the continued growth of self-care driving the demand for safe and beneficial over-the-counter medicines, dietary supplements and consumer medical devices. Americans are prioritizing
January 9, 2023 by Scott Melville
CEO at the Consumer Healthcare Products Association, Scott Melville is the president
January 9, 2023, Opinion
Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection. Now as we welcome 2023, not only has this demand continued, it has accelerated. The drivers of growth and innovation
August 8, 2022 by Scott Melville
Scott Melville is president and chief executive officer of the Consumer Healthcare Products Association
August 8, 2022, Opinion
According to a report (“The Evolution of Self-Care”) released last year by the Consumer Healthcare Products Association (CHPA) and IRI, 70% of Americans are prioritizing self-care practices to support their health and well-being several days a week or more. And thanks to advances in digital health technology, today’s health care consumers have the tools to
January 10, 2022 by Scott Melville
CEO at the Consumer Healthcare Products Association, Scott Melville is the president
January 9, 2023, Opinion
Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection. Now as we welcome 2023, not only has this demand continued, it has accelerated. The drivers of growth and innovation
December 31, 2021 by Scott Melville
Scott Melville President CEO Consumer Healthcare Products Association
Featured Articles, January 10, 2022, Leading Headlines, Opinion, Pharmacy
One of the most enduring outcomes of the global pandemic is the tremendous acceleration of self-care as a cornerstone of health care. Now, more than ever, consumers are taking greater responsibility for, and control over, their own health care. While it’s exciting to see broad industry growth, there’s no denying that consumer demand, and the
January 4, 2021 by Scott Melville
Scott Melville is the president and chief executive officer at the Consumer Healthcare Products Association.
January 4, 2021, Pharmacy
Despite the difficult realities of COVID-19, and the tremendous challenge, pain and uncertainty it has created, 2020 was also a year of incredible progress for self-care in the United States. From manufacturers to retailers, we at Consumer Healthcare Products Association are proud of the pivotal role our extended industry has played in providing and maintaining
January 13, 2020 by Scott Melville
CHPA, Scott Melville
January 6, 2020, Opinion
Welcome to 2020, where, more than ever, patients and caregivers are taking control of their health care decisions and an increasing array of consumer health care products is helping them get well, stay healthy, treat minor ailments and even manage some chronic conditions. The marketplace is evolving before our eyes, including the manufacturers, who are
January 18, 2017 by Scott Melville and Chain Drug Review
Affordable Care Act, CHPA, Consumer Healthcare Products Association, drug take-back programs, FSAs, HSAs, NPLEx, OTC medicines, over-the-counter medications, Restoring Access to Medication Act, Scott Melville
Leading Headlines, Opinion
The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome a new American president and Congress, the country is waiting to see how the regulatory and legislative landscape will evolve. But I am certain that one thing will not change: the continued importance of over-the-counter